RDHL - Redhill Biopharma Ltd logo

RDHL

Redhill Biopharma Ltd

Net โ€”top 1%Rev โ€”top 1%10Y
Hold

RedHill Biopharma Ltd. specializes in developing and commercializing treatments for gastrointestinal and infectious diseases. Key products include Talicia for H. pylori infection and Aemcolo for travelers' diarrhea, alongside a diverse clinical pipeline.

โš•๏ธ Healthcare NASDAQ Listed 2013 $ USD
$1,000 invested 10 years ago โ†’$0today

Score Overview

1 Year
Scoreโ€”
Net Growthโ€”
Net Trendโ€”
Net Income Consistencyโ€”
Rev Growthโ€”
Rev Trendโ€”
Revenue Consistencyโ€”
5 Years
Scoreโ€”
Net Growthโ€”
Net Trend50%
Net Income Consistencyโ€”
Rev Growthโ€”
Rev Trend50%
Revenue Consistencyโ€”
10 Years
Scoreโ€”
Net Growthโ€”
Net Trend33%
Net Income Consistency
Rev Growthโ€”
Rev Trend67%
Revenue Consistency
All Time
Scoreโ€”
Net Growthโ€”
Net Trend27%
Net Income Consistency
Rev Growthโ€”
Rev Trend64%
Revenue Consistency

See the full market ranking โ†’

Redhill Biopharma Ltd fundamental performance

Across Redhill Biopharma Ltd's full reported history, from 2013 to 2024, revenue grew from $ 12K to $ 8M and net income went from -$ 10M to -$ 8M. Revenue increased in 64% of the years measured; net income in 27%.

Net Income x Stock Price

Historical Returns

Historical Returns
PeriodPriceReturn
Last Price2026-08-12
$ 0.59โ€”
1 Year2025-08-12
$ 1.33-55.64%
5 Years2021-08-12
$ 7.27K-99.99%
10 Years2016-08-12
$ 15.69K-100.00%
All Time2013-01-07
$ 11.1K-99.99%

Prices are split & dividend adjusted. All values are reported in USD.

Fundamental Data

Year
2025$ 2M
2024$ 8M-$ 8M$ 4M
2023$ 6M$ 23M$ 6M
2022$ 61M-$ 71M$ 19M
2021$ 85M-$ 97M$ 38M
2020$ 64M-$ 76M$ 29M
2019$ 6M-$ 42M$ 47M
2018$ 8M-$ 38M$ 53M
2017$ 4M-$ 45M$ 46M
2016$ 101K-$ 29M$ 66M
2015$ 3K-$ 21M$ 58M
2014$ 7M-$ 10M$ 22M
IPO2013$ 12K-$ 10M$ 12M

Explore beyond RDHL

You're looking at Redhill Biopharma Ltd. Members apply the same fundamental framework across all 3,860 companies we cover.

$99/year $149 founding price

Unlock Holder Dashboard

30-day money-back guarantee.

Explore other companies